Research, Select, & Monitor Monday, July 06, 2020 1:45:06 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Alimera Sciences Inc$6.06$.305.21%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Alimera Sciences Inc vs Chemicals - Major Diversified

Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is presently focused on diseases affecting the back of the eye, or retina because it believes these diseases are not well treated with current therapies and represent a significant market opportunity. Its product candidate Iluvien(R) is an intravitreal insert containing fluocinolone acetonide, a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease. Iluvien is in development for the treatment of diabetic macular edema (DME). DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness.

Looking at a few key industries, such as chemical manufacturing, one can usually summarize the strength of a nationís economy. So many industries rely on the raw products of these companies. Fuel additives and detergents are probably the most common encounter we have with products from these firms. They also produce pharmaceuticals, polymers, resins, monomers, plastics, agricultural chemicals, and industrial gases. Just a few of the industries that use these items are aerospace, beverage, electronic, food processing, automotive, and construction.
 Totals Company Industry
  Sales: $53.9 Mil $152,519.5 Mil
  Market Cap: $28.7 Mil $285,775.2 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
  Historic Revenue: 14.8% (13.7%)
  Estimated Revenue: (7.2%) (6.5%)
  Historic Earnings: N/A (6.7%)
  Estimated Earnings: N/A 5.0%
  Stock Price (1 Year): (56.3%) (5.8%)
  Cash per Share: (32.0%) (2.6%)
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: N/A 17.0
  Price-to-Sales: .5 N/A
  Price-to-Book: (6.4) 2.9
  Dividend Yield: N/A N/A
  Market Cap: $28.7 Mil $28,577.5 Mil
  Net Margin: (16.0%) 12.1%
  Gross Margin: 87.7% 35.1%
  Return on Equity: N/A .1
  Return on Assets: (.2) .0
  Balance Sheet
  Current Ratio: 2.7 1.6
  Quick Ratio: 2.6 1.1
  Cash Ratio: .8 .3
  Debt-to-Equity: N/A 1.8
  Interest Coverage: (.0) .5
  Relative-Strength Index: N/A N/A

 Other companies in Chemicals - Major Diversified Price Market Cap
  L'Air Liquide ADR  (AIQUY) $29.82 $70,269.0 Mil
  Air Products & Chemicals, Inc.  (APD) $247.42 $55,001.5 Mil
  Du Pont De Nemours & Co., Inc.  (DD) $53.72 $39,677.6 Mil
  Henkel KGaA  (HENKY) $21.27 $37,261.4 Mil
  Dow Chemical Co.  (DOW) $41.59 $30,859.8 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2020 All rights reserved.